Financial Highlights | Lee's Pharmaceutical

Financial Highlights

For the year ended 31 December
HK$'000
2021
2020
Change
Revenue
1,266,157
1,216,716
+4.1%
Gross Profit
806,284
781,066
+3.2%
Gross Profit Margin (%)
63.7%
64.2%
- 0.5%
EBITDA
2,110,444
266,728
+691.2%
Profit from Operations
1,978,583
151,923
+1,202.4%
Profit attributable to shareholders of the Company
1,987,176
129,316
+1,436.7%
Equity attributable to the owners of the Company
2,464,578
2,149,795
+14.6%
Basic EPS
HK 337.58 cents
HK 21.99 cents
+1,435.2%
Diluted EPS
HK 337.35 cents
HK 21.99 cents
+1,434.1%
Total Dividend per Share (Interim + Final)
HK 6.10 cents
HK 5.80 cents
+5.2%